In 2023, the mortality rate for trachea, bronchus or lung malignant neoplasms among women in Germany stood at an actual figure which is not provided in the forecast data. From 2024 onwards, mortality figures are forecasted and appear to follow a slight upward trend, moving from 41.2 units per hundred thousand in 2024 to 41.5 in 2028. The year-on-year increase is minimal, at a consistent 0.1 unit from 2024 to 2028, indicating a steady but slight rise over the forecast period. This increment reflects an average annual growth rate (CAGR) of approximately 0.1% over the last five years.

Future trends to watch for:

Continued evaluation of healthcare policies and advancements in early detection and treatment methods that could potentially impact mortality rates.
The influence of public health initiatives and lifestyle changes on women's health outcomes.
Socio-economic factors affecting healthcare access and their potential impacts on mortality trends.